Clinical Trial Update: Extended Duration Nicotine Replacement Therapy and Bupropion in Smokers With Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating extended duration nicotine replacement therapy with bupropion in smokers with schizophrenia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Schizophrenia

Drugs mentioned

• Nicotine replacement therapy (nicotine replacement therapy)
• bupropion (bupropion)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Nicotine Dependence, Schizophrenia | Phase 4 | Status: TERMINATED